Sapporo Clinical Laboratory Inc. operates within the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sapporo Clinical Laboratory Inc. with three other
drug stores in Asia:
sales of 16.69 billion Japanese Yen [US$158.02 million]
of which 56%
was Pharmaceutical segment),
Sunshine Holdings PLC
of SRI LANKA
(20.83 billion Sri Lanka Rupees [US$112.28 million]
of which 54%
was Healthcare), and
China Jo-Jo Drugstores Inc
based in CHINA
(818.53 million Chinese Renmimbi [US$117.99 million]
of which 63%
was Retail Drugstores).
During the year ended March of 2020, sales at
Sapporo Clinical Laboratory Inc. were ¥17.66 billion (US$167.23 million).
increase of 3.5%
versus 2019, when the company's sales were ¥17.07 billion.
The sales level in 2020 was fairly close to the level five years ago: in 2015, Sapporo Clinical Laboratory Inc. had sales
of ¥17.17 billion.